Breakthrough medication significantly cuts risk of heart attacks and strokes: Lancet study - The Times of India
A newly approved drug for type 2 diabetes and kidney disease, sotagliflozin, has shown remarkable benefits in reducing the risk of heart attacks and s
Comments